References
Colah R, Mukherjee M, Ghosh K (2014) Sickle cell disease in India. Curr Opin Hematol 21:215–223
Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DHK, Steinberg MH (2011) Fetal hemoglobin in sickle cell anemia. Blood 118:19–27
Lettre G, Sankaran VG, Bezerra MA, Arau’jo AS, Uda M, Sanna S, Cao A, Schlessinger D, Costa FF, Hirschhorn JN, Orkin SH (2008) DNA polymorphism at the BCL11A, HBS1L-MYB, and β-globin loci associates with fetal haemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci U S A 105:11869–11874
Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R (2009) Hydroxyurea in sickle cell disease—a study of clinico-pharmacological efficacy in the Indian haplotype. Blood Cells Mol Dis 42:25–31
van den Tweel XW, van der Lee JH, Heijboer H, Peters M, Fijnvandraat K (2010) Development and validation of a pediatric severity index for sickle cell patients. Am J Hematol 85:746–751
Adegoke SA, Kuti BP (2013) Evaluation of clinical severity of sickle cell anemia in Nigerian children. J Appl Hematol 4:58–64
Jiang J, Best S, Menzel S, Silver N, Lai MI, Surdulescu GL, Spector TD, Thein SL (2006) cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 108:1077–1083
Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, Mikkola HK, Hirschhorn JN, Cantor AB, Orkin SH (2008) Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322:1839–1842
Cardoso GL, Diniz IG, Silva AN, Cunha DA, Silva Junior JS, Uchôa CT, Santos SE, Trindade SM, Cardoso Mdo S, Guerreiro JF (2014) DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil. Blood Cells Mol Dis 53:176–179
Makani J, Menzel S, Nkya S, Cox SE, Drasar E, Soka D, Komba AN, Mgaya J, Rooks H, Vasavda N, Fegan G, Newton CR, Farrall M, Thein SL (2011) Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood 117:1390–1392
Galanello R, Sanna S, Perseu L, Sollaino MC, Satta S, Lai ME, Barella S, Uda M, Usala G, Abecasis GR, Cao A (2009) Amelioration of Sardinian beta0 thalassemia by genetic modifiers. Blood 114:3935–3937
Kar BC, Satapathy RK, Kulozik AE, Kulozik M, Sirr S, Serjeant BE, Serjeant GR (1986) Sickle cell disease in Orissa State, India. Lancet 22:1198–1201
Kulozik AE, Wainscoat JS, Serjeant GR, Kar BC, Al-Awamy B, Essan GJ, Falusi AG, Haque SK, Hilali AM, Kate S, Ranasinghe WAEP, Weatherall DJ (1986) Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Am J Hum Genet 39:239–244
Roy P, Bhattacharya G, Mandal A, Dasgupta UB, Banerjee D, Chandra S, Das M (2012) Influence of BCL11A, HBS1L-MYB, HBBP1 single nucleotide polymorphisms and the HBG2 XmnI polymorphism On Hb F levels. Hemoglobin 36:592–599
Bhanushali AA, Patra PK, Nair D, Verma H, Das BR (2015) Genetic variant in the BCL11A (rs1427407), but not HBS1L-MYB (rs6934903) loci associate with fetal hemoglobin levels in Indian sickle cell disease patients. Blood Cells Mol Dis 54:4–8
Acknowledgments
This study was funded by the Department of Biotechnology, Government of India.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Upadhye, D., Jain, D., Trivedi, Y. et al. Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients. Ann Hematol 95, 1201–1203 (2016). https://doi.org/10.1007/s00277-016-2675-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-016-2675-1